Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Sep 9 2025
Feb 14 2026
Mar 6 2025
Jan 12 2026
Oct 22 2025